Skip to main content

Consultant Pharmacist Certificate Program for Initial Licensure

Tracking # 20-1104786

$499.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Home Study

Course overview

This course will provide insight into regulatory requirements and clinical knowledge necessary to practice as a consultant pharmacist in the state of Florida. A licensed consultant pharmacist provides expert clinical guidance to healthcare providers on the appropriate use of medications in a variety of practice settings. This role includes collaborating with members of the health care team by providing recommendations to ensure safe and effective drug therapy, as well as guidance on regulatory compliance, facility medication utilization trends and appropriate medication storage. Consultant pharmacists perform medication regimen reviews based on a patient's health history to evaluate the appropriateness, safety, benefits, risks, and cost-effectiveness of medication therapy. The consultant pharmacist may provide alternate treatment options and medication management guidance, including drug monitoring, administration, and storage. Opportunities in consultant pharmacy can be expanded with a pharmacist and supervising physician Collaborative Practice Agreement. Under this agreement, a pharmacist will be able to perform patient assessments and develop treatment plans. Testing and treating minor, nonchronic health conditions, under an established written protocol, can also provide additional opportunities to expand a consulting practice. Learners will successfully view recorded lecture content available online via the Canvas Learning Management System, complete required readings, and assessment activities for a total of 20.0 hours of CPE.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Pharmacy

Consultant Pharmacist

20h In-Depth Analysis of Consultant Pharmacist Practice

Pharmacist

20h General

Disclosure statements

Program speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.